PAG Transparency information

Otsuka Pharma Scandinavia AB (OPSAB) is a subsidiary of Otsuka Pharmaceutical Europe Ltd (OPEL) who is a member of the national pharmaceutical industry associations in the Nordic region (Läkemedelsindustriföreningen (LIF), Legemiddelindustrien (LMI)) which incorporates the EFPIA disclosure code as part of the national codes in the Nordic region.  As such Otsuka Pharma Scandinavia AB (OPSAB) agrees to publically disclose certain transfers of value made directly or indirectly to healthcare professionals and healthcare organisations. This includes, but is not limited to:

• Travel and accommodation
• Fee for services and all consultancy
• Any agreement related expenses or benefits (e.g. taxi, out of pocket expenses)
• Contribution towards events and costs of meetings paid to healthcare organisations
• Grants and donations
• Research and development (in aggregate)

Where an HCP has not granted consent to disclosure on an individually named basis, these transfers of value are reported in aggregate. Otsuka Pharma Scandinavia AB (OPSAB) disclosure data can be found presented by country on the relevant tabs. Any questions relating to this information should be directed to info@otsuka.se. DISCLAIMER

• The publication of this data is necessary in order to comply with the transparency obligations arising from the EFPIA code
• Access to the website of Otsuka Pharmaceutical Europe Ltd or any of its affiliate companies does not grant any right to use the disclosed data for any purpose whatsoever.
• Otsuka Pharmaceutical Europe Ltd and its affiliates have taken reasonable steps in order to avoid indexation of the data on this website through public search engines.

Support to patient organisations and not-for-profit

Year	Country	External Stakeholder Group	Amount	Currency	Description
2023	Sweden	Schizofreniförbundet	4572	SEK	Panel discussion 2 - the patient perspective
	Sweden	Schizofreniförbundet	30 000	SEK	Workshop with "erfarenhetsgruppen" on Socialstyrelsen report on Schizophrenia guidelines
	Sweden	Schizofreniförbundet	4500	SEK	Panel discussion 1 - the patient perspective
2022	Belgium	AIRG (Association pour l’Information et la Recherche sur les maladies Rénales Génétiques)	1000	EUR	Annual patient meeting of AIRG
2020	Netherlands	Nier Patienten Vereniging (NVN)	3000	EUR	translation ADPKD routemap
	Belgium	AIRG-Belgium	4000	EUR	the Annual day for Kidney Diseases
	Netherlands	Nierpatienten Vereniging Nederlands	6000	EUR	A combination of a webinar and a physical meeting. We will invite keynote speakers and facilitate exchange of experiences among patients. We are planning to rent a corona-proof venue and arrange a studio to record the webinar for those patients who are unable to physically participate.
	Sweden	Schizofreniförbundet	70 000	SEK	Printing of brochure re. mental illness
	Denmark	Skizofreniforeningen	35,000	DKK	Nordic meeting with focus on severe mental illness
2019	Nordic meeting held in Sweden	Skizofreniforeningen DK	7,400	DKK	To support for a Nordic collaboration between PAGs
	Nordic meeting held in Sweden where Finnish, Norwegian PAG attendees where present	Schizofreniföreningen SE	26,325	SEK	To support for a Nordic collaboration between PAGs

* The support provided by Otsuka is in no way intended as an inducement to prescribe, supply, recommend, buy or sell any products of Otsuka or any Otsuka group company, nor does Otsuka expect any favourable treatment by the institutions or any of their staff towards Otsuka personnel or representatives.